Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain

被引:45
作者
Hagiwara, Y
Iwasaki, T
Asanuma, H
Sato, Y
Sata, T
Aizawa, C
Kurata, T
Tamura, S
机构
[1] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan
[2] Kitasato Inst, Biol Res Ctr, Kitamoto, Saitama 3640026, Japan
关键词
cholera toxin; heat-labile enterotoxin; intranasal administration; brain damage;
D O I
10.1016/S0264-410X(00)00412-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Effects of intranasal administration of cholera toxin (CT) [or Escherichia coli heat-labile enterotoxin (LT)] B subunits supplemented with a trace amount of the holotoxin. CTB* or LTB*, on the brain were examined in BALB/c mice by comparing with those of the intracerebral injection. Intracerebral injection of CTB* at doses more than 10 mug/mouse caused significant body weight loss and dose-dependent death within 7 days, with localization of conjugates of horseradish peroxidase with CTB (HRP-CTB) in the ventricular system and in the perineural space of olfactory nerves of the nasal mucosa 3 h after injection. Intracerebral injection of CTB* at doses less than 3 mug/mouse (or LTB* at doses less than 27.7 mug/mouse) did not cause any significant body weight loss for 7 days, with localization of HRP-CTB in the brain but not in the nasal mucosa. On the other hand, intranasal administration of 10 mug of CTB* caused localization of HRP-CTB in the nasal mucosa but not in the brain 3 h after administration and caused body weight loss even after 30 administrations. Neither any histological changes of blain tissues nor marl;ed changes in serum biochemical parameters were found in mice after the 30 administrations of CTB* or LTB*. These results suggest that 0.1 mug of CTB* or LTB*, which is known to be close to the minimal effective dose as an adjuvant for nasal influenza vaccine in mice and corresponds to 100 mug per person, can be used as a safe nasal adjuvant without adversely affecting the brain. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1652 / 1660
页数:9
相关论文
共 29 条
[1]   ADJUVANT ACTIVITY OF ESCHERICHIA-COLI HEAT-LABILE ENTERO-TOXIN AND EFFECT ON THE INDUCTION OF ORAL TOLERANCE IN MICE TO UNRELATED PROTEIN ANTIGENS [J].
CLEMENTS, JD ;
HARTZOG, NM ;
LYON, FL .
VACCINE, 1988, 6 (03) :269-277
[2]  
CRAIG JP, 1971, MICROBIAL TOXINS A, V2, P189
[3]   AMINO-ACID-SEQUENCE HOMOLOGY BETWEEN CHOLERA-TOXIN AND ESCHERICHIA-COLI HEAT-LABILE TOXIN [J].
DALLAS, WS ;
FALKOW, S .
NATURE, 1980, 288 (5790) :499-501
[4]   CHOLERA-TOXIN B-SUBUNIT GENE FUSION - STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE CHIMERIC PROTEIN [J].
DERTZBAUGH, MT ;
PETERSON, DL ;
MACRINA, FL .
INFECTION AND IMMUNITY, 1990, 58 (01) :70-79
[5]  
ELSON CO, 1984, J IMMUNOL, V133, P2892
[6]   Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine [J].
Hagiwara, Y ;
Komase, K ;
Chen, Z ;
Matsuo, K ;
Suzuki, Y ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1999, 17 (22) :2918-2926
[7]   Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin [J].
Hashigucci, K ;
Ogawa, H ;
Ishidate, T ;
Yamashita, R ;
Kamiya, H ;
Watanabe, K ;
Hattori, N ;
Sato, T ;
Suzuki, Y ;
Nagamine, T ;
Aizawa, C ;
Tamura, S ;
Kurata, T ;
Oya, A .
VACCINE, 1996, 14 (02) :113-119
[8]  
HASHIGUCCI K, 1997, J JPN ASS INFECT DIS, V71, P153
[9]   Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model [J].
Iwasaki, T ;
Tamura, S ;
Kumasaka, T ;
Sato, Y ;
Hasegawa, H ;
Asanuma, H ;
Aizawa, S ;
Yanagihara, R ;
Kurata, T .
ARCHIVES OF VIROLOGY, 1999, 144 (04) :675-685
[10]   Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine [J].
Komase, K ;
Tamura, S ;
Matsuo, K ;
Watanabe, K ;
Hattori, N ;
Odaka, A ;
Suzuki, Y ;
Kurata, T ;
Aizawa, C .
VACCINE, 1998, 16 (2-3) :248-254